GENEVA, Nov. 6 -- ALVEUS THERAPEUTICS INC. filed a patent application (EP2026/062677) for “NOVEL DUAL AMYLIN CALCITONIN RECEPTOR AGONISTS”. With publication no. WO/2026/229620, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61P 3/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....